2002
DOI: 10.1016/s0091-3057(02)00827-4
|View full text |Cite
|
Sign up to set email alerts
|

The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
40
0

Year Published

2005
2005
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(43 citation statements)
references
References 29 publications
3
40
0
Order By: Relevance
“…Although we did not study locomotor activity or behavioral sensitization in relation to glutamate release in NAcc in this report, it is likely that glutamate release has a modulatory role in locomotion via activation of NMDA receptors (Shoblock et al, 2003), as well as via activation of other glutamate receptor subtypes (Giorgetti et al, 2001;Kim and Vezina, 2002). In the current report, the augmented release of glutamate following acute amphetamine in EC rats, which was blocked completely by MK-801, may explain the exaggerated hyperactivity in response to acute amphetamine noted previously in EC rats (Bowling et al, 1993;Bowling and Bardo 1994).…”
Section: Discussionmentioning
confidence: 87%
“…Although we did not study locomotor activity or behavioral sensitization in relation to glutamate release in NAcc in this report, it is likely that glutamate release has a modulatory role in locomotion via activation of NMDA receptors (Shoblock et al, 2003), as well as via activation of other glutamate receptor subtypes (Giorgetti et al, 2001;Kim and Vezina, 2002). In the current report, the augmented release of glutamate following acute amphetamine in EC rats, which was blocked completely by MK-801, may explain the exaggerated hyperactivity in response to acute amphetamine noted previously in EC rats (Bowling et al, 1993;Bowling and Bardo 1994).…”
Section: Discussionmentioning
confidence: 87%
“…The physical environments that provided Contexts A and B were counterbalanced. Drugs LY379268 (0.3, 1.0, and 3.0 mg) was dissolved in 1.2 M NaOH solution (pH adjusted to 7.4) (Kim and Vezina, 2002;Kim et al, 2005). The bilateral intracranial doses of LY379268 were based on our previous report (Bossert et al, 2004).…”
Section: Apparatusmentioning
confidence: 99%
“…It has recently been reported that group 2 mGluR-selective agonists and antagonists influence hyperlocomotor activity in rodents, after single or repeated administration of drugs of abuse. However, studies concerning their effects on drug-induced behavioral changes have been contradictory (9,10,(35)(36)(37). We addressed whether mGluR2 deficiency affects behavioral changes induced by repeated cocaine administration.…”
Section: Hyperlocomotion Under Novel Environmental and Stressful Condi-mentioning
confidence: 99%
“…Gene targeting and pharmacological studies have indicated that both ionotropic GluRs and mGluRs participate in biochemical and behavioral responses to abused drugs and psychostimulants (44). It has been reported that the group 2 mGluR-selective agonists LY379268 and LY354740 inhibit the hyperlocomotion induced by psychostimulants and psychotomimetic drugs such as amphetamine and phencyclidine (9,10). However, it has also been reported that the group 2 mGluR-selective antagonist (2S)-␣-ethylglutamic acid injected into the NAc similarly inhibit amphetamine-induced hyperlocomotion (35).…”
Section: Changes In Release Of Da and Glutamate In Mglur2 ؊͞؊ Ko Nac Bymentioning
confidence: 99%